伴侶動物診斷市場－全球產業規模、佔有率、趨勢、機會、預測：按動物類型、技術、地區和競爭格局分類，2021-2031年

全球伴侶動物診斷市場預計將從 2025 年的 30.2 億美元成長到 2031 年的 46.1 億美元，複合年成長率為 7.3%。

該產業涵蓋種類繁多的醫療設備、檢測套組、試劑和耗材，用於識別、追蹤和治療貓狗等寵物的疾病。該行業的成長趨勢主要源於人們越來越傾向於將寵物視為家庭成員，從而增加了獸醫服務的支出，並更加重視預防性護理。此外，分子檢測和照護現場（POC​​）等診斷方法的進步，以及感染疾病和慢性病發病率的上升，也對該行業的擴張起到了重要作用。美國寵物用品協會（APPA）發布的《2023-2024年全國寵物飼主調查》顯示，2023年，超過6510萬戶家庭養狗，超過4650萬戶家庭養貓，這充分證明了龐大的寵物數量支撐著這一需求。

儘管預計市場將強勁成長，但先進診斷設備和專業檢測程序的高昂成本是市場發展的主要障礙。這種經濟障礙限制了這些工具的廣泛應用，尤其是在預算緊張的地區和資金有限的小規模獸醫診所。

市場促進因素

全球伴侶動物診斷產業的主要驅動力是寵物數量的成長以及寵物「擬人化」趨勢的日益盛行。隨著飼主越來越將寵物視為家庭的重要成員，他們也更加重視寵物的整體健康，從而推動了對尖端診斷工具的需求成長。這種轉變促進了預防性醫療保健策略的發展，這些策略強調疾病的早期發現和預防，而不僅僅是治療現有疾病。根據美國寵物產品協會 (APPA) 於 2025 年 3 月發布的《2025 年產業趨勢報告》的數據，2024 年美國有 9,400 萬戶家庭至少擁有一隻寵物，較前一年的 8,200 萬戶家庭顯著成長。寵物數量的增加導致需要定期體檢、健康管理和疾病篩檢的寵物群體不斷擴大，直接推動了對診斷設備、專用檢測和試劑的需求。

同時，獸醫支出的激增是推動市場擴張的主要動力。隨著寵物「人性化」程度的加深，飼主更願意為包括複雜診斷評估在內的各種獸醫服務付費。資金的湧入使得獸醫診所能夠採用和利用尖端診斷技術。根據美國寵物用品協會 (APPA) 發布的《2025 年產業趨勢報告》，2024 年美國寵物飼主在獸醫護理和產品購買方面的支出將達到 410 億美元。這筆巨額投資使得高品質的診斷設備得以購置，例如先進的影像設備和分子檢測平台，從而實現更快、更準確的醫療評估。最終，對動物健康領域不斷成長的投資正在推動診斷產業的持續發展。 APPA 也支持這一趨勢，指出 2024 年美國寵物產業的總支出將達到 1,520 億美元。

市場挑戰

專業檢測和先進診斷設備的高昂成本是全球伴侶動物診斷產業擴張的主要障礙。這些經濟限制阻礙了關鍵診斷技術的廣泛應用，尤其是在預算緊張的地區和難以承擔巨額資本投資的小規模獸醫診所。因此，這些小規模診所提供先進診斷方案的能力有限，這限制了高階產品的潛在用戶群體，直接阻礙了市場成長。

此外，高昂的費用也影響寵物飼主，顯著左右飼主在獸醫推薦某些治療或檢查時的選擇。根據美國獸醫協會（AVMA）2026年的數據，81%的受訪獸醫注意到他們的客戶對價格的敏感度有所提高，高於2024年的72%。這種日益增強的經濟謹慎使得診斷程序成為最常被拒絕的獸醫服務，導致對先進診斷技術的整體需求和市場滲透率放緩。

市場趨勢

目前，影響全球伴侶動物診斷領域的主要趨勢之一是轉型為先進的基因組和分子檢測。這提高了診斷的準確性，並加快了複雜疾病的識別。這些先進的調查方法使獸醫能夠以極高的精確度識別特定的癌症、遺傳易感性和傳染性病原體。透過在分子層面上識別健康問題，獸醫可以實施個人化的治療和預防策略，從而顯著改善患者的預後。為了展示這一潛力，VolitionRx有限公司於2026年1月8日宣布，其Nu.Q® Vet Feline檢測已成功在臨床數據中準確識別超過80%的貓淋巴瘤，同時保持了100%的特異性。如此可靠的性能最終增強了寵物飼主對高科技診斷價值的信心。

同時，機器學習和人工智慧在診斷流程中的應用正透過提高診斷的準確性和營運效率，變革獸醫領域。人工智慧平台能夠處理來自患者病歷、檢測結果和醫學影像的大量訊息，幫助獸醫識別難以察覺的模式，從而做出更明智的醫療決策。這種技術變革在需要快速評估和預測建模的任務中尤其有利。透過利用這些智慧技術，獸醫團隊可以最佳化日常工作流程，專注於直接的病患照護。根據 Instinct Science 於 2026 年 3 月 19 日在《今日獸醫商業》雜誌上發表的一項調查，目前約有 48% 的綜合獸醫診所正在使用人工智慧應用程式，其中許多用於行政任務和醫療記錄管理。這種應用範圍的擴大顯示整個產業正在轉向智慧化的、數據驅動的調查方法。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球伴侶動物診斷市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 動物種類（狗、貓、馬、其他）
  • 依技術分類（臨床生物化學、臨床化學分析、血糖監測、血液氣體及電解質分析、免疫診斷、血液學、尿液檢查等）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美伴侶動物診斷市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲伴侶動物診斷市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區伴侶動物診斷市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲伴侶動物診斷市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美伴侶動物診斷市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球伴侶動物診斷市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• DEXX Laboratories, Inc.
• Zoetis Inc.
• Virbac
• Heska Corporation
• Neogen Corporation
• Bio-Rad Laboratories, Inc.
• INDICAL Bioscience GmbH
• Agrolabo SpA
• ID.vet
• bioMerieux SA

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global market for companion animal diagnostics is expected to expand from USD 3.02 billion in 2025 to USD 4.61 billion by 2031, reflecting a compound annual growth rate (CAGR) of 7.3%. This industry includes a variety of medical devices, testing kits, reagents, and consumable supplies used to identify, track, and treat illnesses in pets like cats and dogs. The sector's upward trajectory is largely fueled by the growing tendency to treat pets as family members, which in turn drives up spending on veterinary services and heightens the focus on preventive healthcare. Additionally, the rising frequency of infectious and chronic diseases, alongside breakthroughs in diagnostic methods such as molecular testing and point-of-care solutions, plays a major role in this expansion. Highlighting the massive pet population supporting this demand, the American Pet Products Association (APPA) 2023-2024 National Pet Owners Survey reported that more than 65.1 million U.S. households had dogs and over 46.5 million had cats in 2023.

Even with strong growth projections, the market faces a major hurdle due to the high expenses linked to sophisticated diagnostic machinery and specialized testing procedures. This economic obstacle limits the broad implementation of these tools, especially in areas with tighter budgets and within smaller-scale veterinary clinics that may lack extensive capital.

Market Driver

The Global companion animal diagnostics industry is largely driven by rising pet ownership and the growing trend of pet humanization. Because owners increasingly view their pets as cherished family members, they place a higher priority on their overall health, generating greater need for state-of-the-art diagnostic tools. This shift encourages proactive healthcare strategies that emphasize early disease detection and preventive measures rather than merely treating existing conditions. Data from the American Pet Products Association (APPA) 2025 State of the Industry Report, published in March 2025, indicates that 94 million U.S. households had a minimum of one pet in 2024, a notable rise from 82 million the previous year. This growing number of pets creates a broader patient base needing routine exams, health monitoring, and disease screenings, directly boosting the demand for diagnostic instruments, specialized testing, and reagents.

At the same time, a surge in veterinary healthcare spending serves as a major catalyst for market expansion. Motivated by the humanization of their pets, owners are showing a greater readiness to pay for extensive veterinary services, which includes complex diagnostic evaluations. This influx of funding allows veterinary clinics to integrate and employ cutting-edge diagnostic innovations. The 2025 APPA State of the Industry Report noted that U.S. pet owners allocated $41.0 billion toward veterinary care and product purchases in 2024. These significant financial contributions facilitate the purchase of premium diagnostic machinery, such as sophisticated imaging devices and molecular testing platforms, that improve the speed and precision of medical assessments. Ultimately, this heightened financial dedication to animal health fuels the ongoing growth of the diagnostics sector, supported by the fact that overall U.S. pet industry spending hit $152 billion in 2024 according to the APPA.

Market Challenge

The steep prices of specialized tests and sophisticated diagnostic machinery pose a major obstacle to the expansion of the worldwide companion animal diagnostics industry. Such financial constraints prevent the broad utilization of crucial diagnostic technologies, especially in areas with limited budgets and among smaller veterinary clinics that find large capital expenditures difficult to manage. As a result, the ability of these smaller practices to provide a full spectrum of advanced diagnostic options is diminished, which directly restricts the market's growth by limiting the number of potential users for these high-end products.

The burden of these high expenses also affects pet owners, heavily swaying their choices when veterinarians recommend specific treatments or tests. Based on data from the American Veterinary Medical Association (AVMA) in 2026, 81% of polled veterinarians noticed an increase in client price sensitivity compared to 72% in 2024. Because of this heightened financial caution, diagnostic procedures have become the most commonly declined veterinary services, subsequently dampening the overall demand and market penetration for advanced diagnostic technologies.

Market Trends

A major trend currently shaping the global companion animal diagnostics sector is the transition toward sophisticated genomic and molecular testing, which delivers higher accuracy and quicker identification of complicated ailments. These advanced methodologies allow veterinary professionals to pinpoint specific cancers, genetic vulnerabilities, and infectious agents with exceptional precision. By recognizing health issues at the molecular stage, veterinarians can implement customized therapies and proactive care strategies that significantly enhance patient outcomes. Demonstrating this potential, VolitionRx Limited announced on January 8, 2026, that clinical data for its Nu.Q(R) Vet Feline assay showed the test successfully identified more than 80% of feline lymphomas while maintaining 100% specificity. Such reliable performance ultimately builds stronger trust among pet owners regarding the value of high-tech diagnostics.

At the same time, incorporating machine learning and artificial intelligence into diagnostic procedures is transforming the veterinary field through enhanced precision and operational efficiency. Platforms driven by AI can process vast amounts of information from patient histories, laboratory findings, and medical imaging, helping veterinarians spot difficult-to-detect patterns and formulate well-informed medical choices. This technological shift is especially beneficial for tasks that demand quick evaluations and predictive modeling. By utilizing these smart technologies, veterinary teams can optimize their daily workflows and redirect their focus toward direct patient treatment. A survey by Instinct Science, shared by Today's Veterinary Business Staff on March 19, 2026, revealed that approximately 48% of general veterinary clinics now incorporate AI applications, mostly for administrative tasks and managing medical records. This growing acceptance highlights a wider industry pivot toward intelligent, data-centric diagnostic methodologies.

Key Market Players

• DEXX Laboratories, Inc.
• Zoetis Inc.
• Virbac
• Heska Corporation
• Neogen Corporation
• Bio-Rad Laboratories, Inc.
• INDICAL Bioscience GmbH
• Agrolabo SpA
• ID.vet
• bioMerieux S.A.

Report Scope

In this report, the Global Companion Animal Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Companion Animal Diagnostics Market, By Animal Type

• Dogs
• Cats
• Horses
• Others

Companion Animal Diagnostics Market, By Technology

• Clinical Biochemistry
• Clinical Chemistry Analysis
• Glucose Monitoring
• Blood Gas & Electrolyte Analysis
• Immunodiagnostics
• Hematology
• Urinalysis
• Others

Companion Animal Diagnostics Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Companion Animal Diagnostics Market.

Available Customizations:

Global Companion Animal Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Companion Animal Diagnostics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Animal Type (Dogs, Cats, Horses, Others)
  • 5.2.2. By Technology (Clinical Biochemistry, Clinical Chemistry Analysis, Glucose Monitoring, Blood Gas & Electrolyte Analysis, Immunodiagnostics, Hematology, Urinalysis, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Companion Animal Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Animal Type
  • 6.2.2. By Technology
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Companion Animal Diagnostics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Animal Type
      • 6.3.1.2.2. By Technology
  • 6.3.2. Canada Companion Animal Diagnostics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Animal Type
      • 6.3.2.2.2. By Technology
  • 6.3.3. Mexico Companion Animal Diagnostics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Animal Type
      • 6.3.3.2.2. By Technology

7. Europe Companion Animal Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Animal Type
  • 7.2.2. By Technology
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Companion Animal Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Animal Type
      • 7.3.1.2.2. By Technology
  • 7.3.2. France Companion Animal Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Animal Type
      • 7.3.2.2.2. By Technology
  • 7.3.3. United Kingdom Companion Animal Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Animal Type
      • 7.3.3.2.2. By Technology
  • 7.3.4. Italy Companion Animal Diagnostics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Animal Type
      • 7.3.4.2.2. By Technology
  • 7.3.5. Spain Companion Animal Diagnostics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Animal Type
      • 7.3.5.2.2. By Technology

8. Asia Pacific Companion Animal Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Animal Type
  • 8.2.2. By Technology
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Companion Animal Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Animal Type
      • 8.3.1.2.2. By Technology
  • 8.3.2. India Companion Animal Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Animal Type
      • 8.3.2.2.2. By Technology
  • 8.3.3. Japan Companion Animal Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Animal Type
      • 8.3.3.2.2. By Technology
  • 8.3.4. South Korea Companion Animal Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Animal Type
      • 8.3.4.2.2. By Technology
  • 8.3.5. Australia Companion Animal Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Animal Type
      • 8.3.5.2.2. By Technology

9. Middle East & Africa Companion Animal Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Animal Type
  • 9.2.2. By Technology
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Companion Animal Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Animal Type
      • 9.3.1.2.2. By Technology
  • 9.3.2. UAE Companion Animal Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Animal Type
      • 9.3.2.2.2. By Technology
  • 9.3.3. South Africa Companion Animal Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Animal Type
      • 9.3.3.2.2. By Technology

10. South America Companion Animal Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Animal Type
  • 10.2.2. By Technology
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Companion Animal Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Animal Type
      • 10.3.1.2.2. By Technology
  • 10.3.2. Colombia Companion Animal Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Animal Type
      • 10.3.2.2.2. By Technology
  • 10.3.3. Argentina Companion Animal Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Animal Type
      • 10.3.3.2.2. By Technology

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Companion Animal Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. DEXX Laboratories, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Zoetis Inc.
• 15.3. Virbac
• 15.4. Heska Corporation
• 15.5. Neogen Corporation
• 15.6. Bio-Rad Laboratories, Inc.
• 15.7. INDICAL Bioscience GmbH
• 15.8. Agrolabo SpA
• 15.9. ID.vet
• 15.10. bioMerieux S.A.

16. Strategic Recommendations

17. About Us & Disclaimer